Log in Book a Demo

US Pharma & Biotech Cardiology - PPC Market Share Analysis August 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Cardiology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Cardiology – US

Google AI Overview visibility for Pharma & Biotech Cardiology US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 79.2248692435
20.7751307565
79%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 19
81
19%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 2%
Transactional 7%
Navigational 2%
Seasonal 0%
Local 0%
Problem Solving 23%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Cardiology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
repatha.com 64.26
repathahcp.com 22.85
bmscustomerconnect.com 1.82
vyndamax.com 1.65
telyrx.com 1.41
goodrx.com 1.32
vyndamax.pfizerpro.com 1.19
lipitor.com 0.78
leqviohcp.com 0.77
familywize.org 0.43
others 3.52
  • repatha.com - 64.26%
  • repathahcp.com - 22.85%
  • bmscustomerconnect.com - 1.82%
  • vyndamax.com - 1.65%
  • telyrx.com - 1.41%
  • goodrx.com - 1.32%
  • vyndamax.pfizerpro.com - 1.19%
  • lipitor.com - 0.78%
  • leqviohcp.com - 0.77%
  • familywize.org - 0.43%
  • others - 3.52%

Copyright © Adthena. All rights reserved.

In the PPC landscape, Repatha.com dominates with 64.26% click share, followed by Repathahcp.com at 22.85%. Others collectively hold 3.52%, while the rest share the remaining pie.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Cardiology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date repatha.com repathahcp.com vyndamax.com vyndamax.pfizerpro.com bmscustomerconnect.com leqviohcp.com amvuttra.com goodrx.com nexlizet.com telyrx.com
2026/08/01 60.54% 26.51% 1.41% 1.1% 0.44% 0.64% 0.5% 1.1% 0.86% 0.33%
2026/08/02 63.43% 19.19% 1.1% 1.05% 0.9% 1.17% 0.62% 0.69% 1.31% 0.45%
2026/08/03 60.68% 26.92% 1.29% 1.18% 0.5% 0.99% 0.74% 0.66% 0.65% 2.37%
2026/08/04 62.48% 26.76% 1.41% 1.07% 0.15% 0.36% 0.58% 0.54% 1.24% 0.71%
2026/08/05 62.43% 26.32% 1.51% 1.32% 0.34% 0.5% 0.65% 0.66% 0.19% 0%
2026/08/06 60.82% 28.15% 1.92% 1.58% 0.3% 0.46% 0.69% 0.72% 0.47% 0%
2026/08/07 66.18% 20.71% 3.2% 2.58% 0.39% 1.29% 0.88% 0.64% 0.04% 0%
2026/08/08 60.3% 23.35% 2.71% 2.07% 0.32% 1.55% 1% 1.03% 0.05% 0.04%
2026/08/09 59.04% 30.93% 1% 0.78% 0.87% 2.35% 0.33% 0.94% 0.87% 0%
2026/08/10 61.34% 31.95% 1.21% 1.22% 0.37% 0.92% 0.44% 0.33% 0.24% 0%
2026/08/11 57.78% 32.17% 1.75% 1.63% 0.32% 0.46% 0.51% 1.2% 0.13% 0.48%
2026/08/12 53.48% 34.86% 1.47% 1.16% 0.54% 1.77% 0.58% 0.36% 0.11% 1.86%
2026/08/13 61.34% 30.11% 1.99% 1.53% 0.62% 0.94% 0.55% 0.52% 0.18% 0.67%
2026/08/14 62.85% 29.66% 1.2% 0.94% 0.32% 2.21% 0.42% 0.39% 0.41% 0%
2026/08/15 62.31% 28.99% 1.13% 0.86% 0.09% 1.78% 0.44% 1.08% 0.1% 0.78%
2026/08/16 59.53% 30.15% 1.07% 0.88% 0.41% 1.1% 0.51% 0.76% 0.06% 2.64%
2026/08/17 54.98% 34.93% 1.41% 1.33% 0.53% 0.91% 0.64% 0.37% 0.9% 1.34%
2026/08/18 50.03% 37.97% 2.37% 1.99% 0.63% 0.77% 1.18% 0.81% 0.5% 0.33%
2026/08/19 57.68% 33.88% 2.15% 1.65% 0.2% 0.91% 0.68% 0.75% 0.03% 0.5%
2026/08/20 52.03% 37.46% 1.58% 1.21% 0.82% 1.2% 0.5% 0.63% 0.72% 0.2%
2026/08/21 58.38% 32.18% 1.59% 1.36% 0.5% 0.48% 0.47% 0.7% 0.37% 0.82%
2026/08/22 61.06% 29.51% 1.34% 1.01% 0.4% 0.15% 0.39% 1% 0.88% 1.74%
2026/08/23 67.96% 24.85% 0.89% 0.85% 0.39% 0.57% 0.43% 0.61% 0.15% 1.72%
2026/08/24 51.23% 31.77% 1.99% 1.65% 0.54% 0.67% 0.6% 0.49% 0.17% 4.42%
2026/08/25 54.4% 35.81% 1.89% 1.51% 0.54% 1.88% 0.49% 0.42% 0.19% 0.94%
2026/08/26 56.47% 34.2% 1.96% 1.44% 0.53% 0.24% 0.64% 0.78% 0.5% 0.23%
2026/08/27 56.61% 32.89% 1.97% 1.45% 0.57% 2.31% 0.44% 0.57% 0.33% 0.22%
2026/08/28 64.56% 25.52% 1.74% 1.32% 0.76% 1.29% 0.69% 0.52% 0% 0.39%
2026/08/29 60.64% 29.83% 1.46% 1.17% 0.91% 1.16% 0.72% 0.71% 0.22% 0.18%
2026/08/30 59.5% 31.2% 1.43% 1.19% 0.92% 0.15% 0.84% 0.46% 0.19% 0.13%
2026/08/31 58.74% 31.02% 1.81% 1.28% 1.07% 0.9% 0.65% 0.41% 0.01% 0%
  • repatha.com
  • repathahcp.com
  • vyndamax.com
  • vyndamax.pfizerpro.com
  • bmscustomerconnect.com
  • leqviohcp.com
  • amvuttra.com
  • goodrx.com
  • nexlizet.com
  • telyrx.com

Copyright © Adthena. All rights reserved.

Repatha.com led August with fluctuating dominance, peaking mid-month. Repathahcp.com surged steadily, while Vyndamax.com showed modest growth. Telyrx.com spiked late, ending with a diverse landscape.

Market Exposure

Competitor Count for US Pharma & Biotech Cardiology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/08/01 42
2026/08/02 43
2026/08/03 44
2026/08/04 45
2026/08/05 38
2026/08/06 35
2026/08/07 34
2026/08/08 34
2026/08/09 32
2026/08/10 31
2026/08/11 34
2026/08/12 31
2026/08/13 33
2026/08/14 31
2026/08/15 33
2026/08/16 30
2026/08/17 33
2026/08/18 28
2026/08/19 28
2026/08/20 29
2026/08/21 29
2026/08/22 30
2026/08/23 28
2026/08/24 27
2026/08/25 28
2026/08/26 27
2026/08/27 28
2026/08/28 36
2026/08/29 30
2026/08/30 36
2026/08/31 31

Copyright © Adthena. All rights reserved.

August began with 42 advertisers, peaking at 45 by the 4th. A decline followed, reaching 27 on the 24th. The month concluded with a slight recovery to 31 advertisers.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Cardiology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
repathahcp.com 1.59%
bmscustomerconnect.com 0.94%
lipitor.com 0.73%
telyrx.com 0.24%
vyndamax.com 0.19%
secondscount.org -0.11%
mayoclinic.org -0.14%
goodrx.com -0.17%
leqviohcp.com -0.29%
repatha.com -2.76%

Copyright © Adthena. All rights reserved.

Repatha.com saw a significant drop of 2.76, while repathahcp.com surged by 1.59. Bmscustomerconnect.com gained 0.94, and lipitor.com rose by 0.73.

Campaign Efficiency

US Pharma & Biotech Cardiology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date repathahcp.com repatha.com medchemexpress.com leqviohcp.com amvuttra.com vyndamax.com vyndamax.pfizerpro.com goodrx.com lipitor.com telyrx.com
2026/08/01 41.3% 30.15% 5.39% 1.39% 1.66% 1.21% 1.32% 1.83% 0.36% 1.02%
2026/08/02 32.22% 25.84% 1.55% 2.43% 1.96% 0.86% 1.23% 0.93% 12.02% 1.14%
2026/08/03 42.48% 30.8% 1.35% 2.43% 2.11% 1.03% 1.29% 0.79% 0.04% 6.98%
2026/08/04 46.31% 30.05% 1.26% 0.87% 2.23% 1.16% 1.29% 0.77% 0.22% 2.76%
2026/08/05 43.62% 32.66% 0.89% 1.84% 2.21% 1.3% 1.7% 0.79% 0.23% 0.01%
2026/08/06 47.28% 27.31% 4.49% 0.92% 2.54% 1.72% 2.18% 0.89% 0.27% 0.01%
2026/08/07 41.84% 31.42% 0.09% 1.89% 3.41% 3.24% 3.56% 1.01% 0.22% 0%
2026/08/08 44.56% 22.32% 2.53% 1.57% 3.96% 2.52% 2.77% 1.35% 0.34% 0.56%
2026/08/09 50.33% 29.26% 1.15% 3.16% 1.1% 0.83% 0.94% 1.66% 0.19% 0%
2026/08/10 53.55% 33.54% 0.73% 1.35% 1.67% 1.06% 1.55% 0.42% 0.13% 0%
2026/08/11 51.62% 29.13% 2.13% 0.84% 1.68% 1.43% 1.96% 1.84% 0.15% 1.12%
2026/08/12 52.75% 24.29% 1.89% 3.16% 1.9% 1.11% 1.28% 0.41% 0.17% 5.15%
2026/08/13 56.6% 26.09% 0.02% 1.69% 2.2% 1.91% 2.07% 0.71% 0.24% 2.73%
2026/08/14 52.58% 32.86% 1.99% 3.87% 1.6% 1.09% 1.23% 0.44% 0.15% 0.01%
2026/08/15 50.27% 32.66% 0.87% 2.89% 1.56% 0.97% 1.11% 0.85% 0.12% 2.78%
2026/08/16 48.62% 28.81% 2.11% 1.99% 1.71% 0.87% 1.08% 1.27% 0.15% 6.83%
2026/08/17 54.2% 27.29% 0.41% 1.32% 2.02% 1.11% 1.55% 0.42% 0.16% 3.55%
2026/08/18 55.44% 23.73% 0.08% 0.68% 3.81% 1.87% 2.28% 0.8% 0.14% 1.31%
2026/08/19 56.53% 27.03% 0.65% 1.28% 2.33% 1.96% 2.11% 0.81% 0.28% 2.19%
2026/08/20 56.62% 27.17% 0.72% 1.15% 1.45% 1.21% 1.35% 0.93% 0.09% 0.79%
2026/08/21 54.94% 28.79% 0.76% 0.74% 1.52% 1.33% 1.62% 1.12% 0.11% 2.34%
2026/08/22 51% 29.56% 0.17% 0.29% 1.23% 1.13% 1.36% 1.3% 0.16% 5.78%
2026/08/23 48.59% 33.22% 0.01% 1.27% 1.61% 0.84% 1.27% 1.1% 0.11% 6.77%
2026/08/24 44.99% 19.06% 0.01% 1.23% 1.56% 1.45% 1.62% 0.41% 13.65% 9.92%
2026/08/25 58.12% 25.61% 0.89% 1.8% 1.48% 1.53% 1.76% 0.43% 0.06% 2.67%
2026/08/26 57.42% 26.1% 0% 0.41% 2.14% 1.65% 1.69% 0.7% 0.12% 0.97%
2026/08/27 56.37% 26.23% 1.41% 2.47% 1.53% 1.66% 1.75% 0.56% 0.13% 0.96%
2026/08/28 47.62% 30.88% 2.56% 1.69% 2.57% 1.61% 1.76% 0.61% 0.12% 1.12%
2026/08/29 51.69% 29.36% 1.84% 1.4% 2.52% 1.27% 1.53% 0.72% 0.06% 0.49%
2026/08/30 54.55% 26.87% 1.35% 0.18% 2.93% 1.23% 1.43% 0.48% 0.12% 0.22%
2026/08/31 52.52% 26.93% 3.98% 2.27% 2.16% 1.49% 1.46% 0.47% 0.12% 0%
  • repathahcp.com
  • repatha.com
  • medchemexpress.com
  • leqviohcp.com
  • amvuttra.com
  • vyndamax.com
  • vyndamax.pfizerpro.com
  • goodrx.com
  • lipitor.com
  • telyrx.com

Copyright © Adthena. All rights reserved.

In August 2026, repathahcp.com led with a steady rise, peaking at 58.12% on the 25th. Repatha.com fluctuated, ending at 26.93%. Medchemexpress.com and leqviohcp.com showed minor variations. Telyrx.com spiked on the 24th, while lipitor.com had notable peaks on the 2nd and 24th.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology - Last month
  1. 1
    Official Rx ELIQUIS®(apixaban) - $10 Co-pay Card Eligibility https://eliquis.bmscustomerconnect.com/savings-support

    Visit The Patient Site To Find Important Safety Info, Prescribing Info & Boxed Warnings. Find Out If You Are Eligible For Co-pay Savings Or Talk To...

  2. 2
    Repatha® (evolocumab) - Official Site For Patients https://www.repatha.com/

    Visit the Official Patient Website for Product Information About Repatha. Learn More About Financial Support And Coverage. See Copay Eligibility Information. What Is Repatha®? Side Effects of Repatha®. Is Repatha Right For Me?

  3. 3
    Repatha® (evolocumab) - Latest Repatha Info https://www.repathahcp.com/

    Visit The Official HCP Site & See What Your Peers Are Saying About Repatha. Watch A Video. Find Information on Repatha Broad Coverage and Eligibility, Affordability and Access.

  4. 4
    The Most Common Blood Pressure Medication Types & Names https://www.telyrx.com/

    Confused about your blood pressure prescription? From ACE inhibitors and Beta Blockers to Calcium Channel Blockers, we break down common blood pressure medication names and types.

  5. 5
    VYNDAMAX® (tafamidis) - An FDA Approved Medication https://www.vyndamax.com/about

    Watch Jack Nicklaus Discuss Why He Incorporated VYNDAMAX® In His Journey.

Copyright © Adthena. All rights reserved.

In the competitive world of pharmaceuticals, top-performing PPC ads reveal strategic messaging. Eliquis emphasizes affordability with a $10 co-pay card, while Repatha targets both patients and healthcare professionals with comprehensive product information and financial support. TelyRx simplifies blood pressure medication choices, and Vyndamax leverages celebrity endorsement for credibility.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.